Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors:

Patients with autoimmune rheumatic diseases (ARD) have an increased risk for tuberculosis (TB). The use of tumor necrosis factor inhibitors (TNFi) and glucocorticoids in these patients has been ass...